GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹475 Cr | ₹29 Cr | ₹-251 Cr | ₹-119 Cr | ₹300 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹475 Cr |
Mar2024 | ₹29 Cr |
Mar2023 | ₹-251 Cr |
Mar2022 | ₹-119 Cr |
Mar2021 | ₹300 Cr |
How is Net Cash Inflow / Outflow of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹475 Cr | 1,523.94 | |
Mar2024 | ₹29 Cr | Positive | |
Mar2023 | ₹-251 Cr | Negative | |
Mar2022 | ₹-119 Cr | Negative | |
Mar2021 | ₹300 Cr | - |
Compare Net Cash Inflow / Outflow of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹54,924.6 Cr | -1.2% | -2.3% | 27.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -1.2% |
-2.3% |
27.2% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses